The rate of regimen modification in the daily therapy group was lower than in previous studies ( 13 , 14 ), resulting in a smaller effect size for the primary endpoint that did not reach statistical significance.
← all excerpts
Intermittent versus Daily Therapy for Noncavitary <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Open-Label Randomized Trial.
1
—
—